Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 107 Records) |
Query Trace: Leukemia and TPMT[original query] |
---|
Association between the TPMT*3C (rs1142345) Polymorphism and the Risk of Death in the Treatment of Acute Lymphoblastic Leukemia in Children from the Brazilian Amazon Region. Genes 2020 9 11 (10): . Cardoso de Carvalho Darlen, Pereira Colares Leitão Luciana, Mello Junior Fernando Augusto Rodrigues, Vieira Wanderley Alayde, Souza Tatiane Piedade de, Borges Andrade de Sá Roberta, Cohen-Paes Amanda, Rodrigues Fernandes Marianne, Santos Sidney, Salim Khayat André, Pimentel de Assumpção Paulo, Pereira Carneiro Dos Santos N |
NUDT15 polymorphism in healthy children with Bai nationality in Yunnan of China. Pediatrics international : official journal of the Japan Pediatric Society 2020 9 63 (7): 790-796. Pu Gangling, Wang Yali, Duan Shaoqin, Chen Jingpei, Yang Chunhui, Cui Tingting, Fang Chunlian, Zhou Yan, Zhang Han, Tian X |
Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT. Journal of translational medicine 2020 Jul 18 (1): 265. Park Yoomi, Kim Hyery, Seo Heewon, Choi Jung Yoon, Ma Youngeun, Yun Sunmin, Min Byung-Joo, Seo Myung-Eui, Yoo Keon Hee, Kang Hyoung Jin, Im Ho Joon, Kim Ju H |
Association of NUDT15*3 and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia. Genes 2020 May 11 (6): . Kodidela Sunitha, Dorababu Patchava, Thakkar Dimpal N, Dubashi Biswajit, Sundaram Rajan, Muralidharan Niveditha, Nidanapu Ravi Prasad, Aribandi Anil, Pradhan Suresh Chandra, Uppugunduri Chakradhara Rao Satyanaraya |
Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia. Frontiers in pharmacology 2020 4 11 267. Cao Minyuan, Yin Dandan, Qin Yun, Liao Fei, Su Yali, Xia Xuyang, Gao Ju, Zhu Yiping, Zhang Wei, Shu Yang, Lu Xiao |
Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants. Pediatric research 2020 Mar . Wang Der-Shiun, Yu Chih-Hsiang, Lin Chien-Yu, Chang Ya-Hsuan, Lin Kai-Hsin, Lin Dong-Tsamn, Jou Shiann-Tarng, Lu Meng-Yao, Chang Hsiu-Hao, Lin Shu-Wha, Chen Hsuan-Yu, Yang Yung- |
[Genetic basis of subsequent malignant neoplasms]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2020 61 (9): 1174-1178. Yoshida Masanori, Kato Motohi |
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia. Pediatric hematology and oncology 2020 Nov 1-12. Dreisig Karin, Brünner Emilie Damgaard, Marquart Hanne V, Helt Louise Rold, Nersting Jacob, Frandsen Thomas Leth, Jonsson Olafur Gisli, Taskinen Mervi, Vaitkeviciene Goda, Lund Bendik, Abrahamsson Jonas, Lepik Kristi, Schmiegelow Kje |
TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia. Journal of personalized medicine 2021 8 11 (8): . Jantararoungtong Thawinee, Wiwattanakul Supaporn, Tiyasirichokchai Rawiporn, Prommas Santirhat, Sukprasong Rattanaporn, Koomdee Napatrupron, Jinda Pimonpan, Rachanakul Jiratha, Nuntharadthanaphong Nutthan, Pakakasama Samart, Anurathapan Usanarat, Hongeng Suradej, Sukasem Chonlaph |
Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2021 8 32 (2): 60-66. Moriyama Takaya, Yang Wenjian, Smith Colton, Pui Ching-Hon, Evans William E, Relling Mary V, Bhatia Smita, Yang Jun |
Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT. Scientific reports 2021 5 11 (1): 9676. Kim Hyery, You Seungwon, Park Yoomi, Choi Jung Yoon, Ma Youngeun, Hong Kyung Tak, Koh Kyung-Nam, Yun Sunmin, Lee Kye Hwa, Shin Hee Young, Lee Suehyun, Yoo Keon Hee, Im Ho Joon, Kang Hyoung Jin, Kim Ju H |
Methotrexate polyglutamate quantification for clinical application in patients with pediatric acute lymphoblastic leukemia in association with genetic polymorphisms. Journal of pharmaceutical and biomedical analysis 2021 5 201 114124. Choi Rihwa, Chun Mi Ryung, Park Jisook, Won Hojeong, Kim Seonwoo, Lee Ji Won, Ju Hee Young, Cho Hee Won, Hyun Ju Kyung, Koo Hong Hoe, Yi Eun Sang, Lee Soo-Yo |
The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic Leukemia. Children (Basel, Switzerland) 2021 4 8 (3): . Lee Jae Min, Shim Ye Jee, Kim Do-Hoon, Jung Nani, Ha Jung-So |
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia. Leukemia 2021 Mar . Stanulla Martin, Schaeffeler Elke, Möricke Anja, Buchmann Swantje, Zimmermann Martin, Igel Svitlana, Schmiegelow Kjeld, Flotho Christian, Hartmann Hans, Illsinger Sabine, Sauerbrey Axel, Junk Stefanie V, Schütte Peter, Hinze Laura, Lauten Melchior, Modlich Simon, Kolb Reinhard, Rossig Claudia, Schwabe Georg, Gnekow Astrid K, Fleischhack Gudrun, Schlegel Paul Gerhard, Schünemann Holger J, Kratz Christian P, Cario Gunnar, Schrappe Martin, Schwab Matthi |
Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients. Journal of pediatric genetics 2021 Mar 10 (1): 29-34. Khaeso Kanyarat, Nakkam Nontaya, Komwilaisak Patcharee, Wongmast Piyathida, Chainansamit Su-On, Dornsena Areerat, Kanjanawart Sirimas, Vannaprasaht Suda, Tassaneeyakul Wichitt |
TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy. Pharmacogenomics and personalized medicine 2021 2 14 199-210. Rosdiana Dewi Selvina, Setiabudy Rianto, Andalusia Rizka, Gatot Djajadiman, Louisa Melva, Bardosono Saptawati, Instiaty Instia |
ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia. Pediatric hematology and oncology 2021 10 39 (3): 254-266. Fan Paroni O L, Leung Kam-Tong, Chan Kathy Y Y, Leung Alex W K, Lam Grace K S, Chow Terry T W, Cheng Frankie W T, Yuen Liz Y P, Moriyama Takaya, Yang Jun J, Li Chi-Ko |
Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China. Frontiers in pediatrics 2021 10 9 719803. Mao Xiaoyan, Yin Runxiu, Sun Gaoyuan, Zhou Yan, Yang Chunhui, Fang Chunlian, Wu Yuhong, Cui Tingting, Liu Li, Gan Jiaxin, Tian X |
NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy. Pharmacogenomics and personalized medicine 2021 10 14 1303-1313. Pai Aswin Anand, Mohan Ajith, Benjamin Esther Sathya Bama, Illangeswaran Raveen Stephen Stallon, Xavier Raj Infencia, Janet Nancy Beryl, Arunachalam Arun Kumar, Kavitha M L, Kulkarni Uday, Devasia Anup J, Fouzia N A, Abraham Aby, Srivastava Alok, George Biju, Mathews Vikram, Korula Anu, Balasubramanian Poonkuzha |
DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes. PloS one 2021 1 16 (1): e0245667. Ju Hee Young, Lee Ji Won, Cho Hee Won, Hyun Ju Kyung, Ma Youngeun, Yi Eun Sang, Yoo Keon Hee, Sung Ki Woong, Choi Rihwa, Koo Hong Hoe, Lee Soo-Yo |
Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia. Frontiers in pharmacology 2020 11 594262. Burgueño-Rodríguez Gabriela, Méndez Yessika, Olano Natalia, Dabezies Agustín, Bertoni Bernardo, Souto Jorge, Castillo Luis, da Luz Julio, Soler Ana Mar |
[Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2021 Nov 42 (11): 911-916. Hao Q S, Wang Z, Fang Q Y, Gong X Y, Liu K Q, Li Y, Wei H, Wang Y, Li Q H, Wang M, Tian Z, Wang J X, Mi Y |
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations. Leukemia 2022 6 36 (7): 1749-1758. Toksvang Linea N, Lee Shawn H R, Yang Jun J, Schmiegelow Kje |
Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia. Colombia medica (Cali, Colombia) 2022 4 52 (3): e2074569. Correa-Jimenez Oscar, Yunis Juan José, Linares-Ballesteros Adriana, Sarmiento-Urbina Isab |
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients. Pediatric hematology and oncology 2022 2 39 (6): 561-570. Nghia Huynh, Than Huynh Huu, Dong Cao Van, Oanh Tran Thi Kieu, Truc Vo Thi Thanh, Ngan Cai Thi Thu, Ngon Huynh Thien, Binh Nguyen Tan, Dung Phu Chi, Anh Vu Hoang, Xinh Phan T |
NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. Drug metabolism and pharmacokinetics 2022 1 43 100436. Khaeso Kanyarat, Komvilaisak Patcharee, Chainansamit Su-On, Nakkam Nontaya, Suwannaying Kunanya, Kuwatjanakul Pitchayanan, Hikino Keiko, Dornsena Areerat, Kanjanawart Sirimas, Laoaroon Napat, Vannaprasaht Suda, Taketani Takeshi, Tassaneeyakul Wichitt |
Genetic variants of genes involved in thiopurine metabolism pathway are associated with 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia patients from Ethiopia. Frontiers in pharmacology 2023 5 14 1159307. Awol Mekonnen Ali, Haileyesus Adam, Daniel Hailu, Ephrem Engidawork, Rawleigh Howe, Teferra Abula, Marieke J H Coen |
TPMT intermediate metabolizer status and thiopurine-associated toxicity during maintenance therapy in childhood acute lymphoblastic leukemia. Clinical pharmacology and therapeutics 2023 3 . Schwarz Ute I, Woldanski-Travaglini Morgan, Swanston Valerie, Mikhail Mariam, Cacciotti Chantel, Cairney Elizabeth, Patel Serina, Seelisch Jennifer, Tole Soumitra, Wilejto Marta, Tirona Rommel G, Kim Richard B, Zorzi Alexandra |
Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine. Therapeutics and clinical risk management 2023 12 19 1005-1018. Jennifer Gallardo-Cóndor, Pablo Naranjo, Sebastián Atarihuana, Dayana Coello, Patricia Guevara-Ramírez, Rodrigo Flores-Espinoza, Germán Burgos, Andrés López-Cortés, Alejandro Cabrera-Andra |
Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 10 168 115706. Xando Díaz-Villamarín, Emilio Fernández-Varón, Michelle Carolina Rojas Romero, José Luis Callejas-Rubio, José Cabeza-Barrera, Alba Rodríguez-Nogales, Julio Gálvez, Rocío Mor |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: